ThursdayJan 15, 2026 9:00 am

TinyGemsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) Demonstrates First Scalable, On-Chip Cryogenic Control of Gate-Model Qubits

D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software, and services and the world’s first commercial supplier of quantum computers, recently announced a breakthrough in gate-model quantum computing with the successful demonstration of scalable on-chip cryogenic control of qubits. This industry-first milestone advances the development of commercially viable gate-model quantum computers by significantly reducing the wiring required to control large numbers of qubits without degrading qubit fidelity. This achievement validates that the on-chip cryogenic control technology D-Wave developed for its commercial annealing quantum processing units (QPUs) can also be applied to its gate-model architectures. In D-WaveTM…

Continue Reading

WednesdayJan 14, 2026 9:20 am

TinyGemsBreaks – ParaZero Technologies Ltd. (NASDAQ: PRZO) Engages IBN to Expand Investor and Corporate Communications Reach

ParaZero Technologies (NASDAQ: PRZO) an aerospace defense company focused on smart, autonomous solutions for manned and unmanned aerial systems, has engaged IBN to support its corporate communications and investor outreach strategy. ParaZero specializes in multi-layered Counter-Unmanned Aircraft System (“Counter-UAS”) technologies designed to neutralize hostile drones in complex and RF-denied environments, including urban and strategic infrastructure settings. Through the engagement, IBN will leverage its global investor-focused distribution network, encompassing more than 5,000 syndication outlets, newsletters, social media channels, blogs, and InvestorWire services, to increase visibility for ParaZero’s expanding defense portfolio, which reflects ongoing collaboration with Israeli defense authorities and international security…

Continue Reading

TuesdayJan 13, 2026 9:50 am

TinyGemsBreaks – GridAI Technologies Corp. (NASDAQ: GRDX) Moves From Grid Intelligence Narrative to Execution Test

GridAI Technologies (NASDAQ: GRDX) sits at a critical inflection point for the grid intelligence sector, where rising power demand, constrained infrastructure timelines, and the need for real-time coordination have pushed software-driven orchestration from concept to operational necessity. The company’s relevance no longer hinges on vision or positioning but on measurable execution, specifically the amount of electrical load it actively forecasts, coordinates, and optimizes in live environments. GridAI operates at the control layer of energy economics, where customer trust is earned through consistent performance rather than pilots or demonstrations, and where the transition from testing to dependence signals durable adoption. For…

Continue Reading

TuesdayJan 13, 2026 9:40 am

TinyGemsBreaks – LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Engages IBN to Support Corporate Communications Strategy

LIXTE Biotechnology Holdings (NASDAQ: LIXT), a clinical-stage pharmaceutical company focused on advancing differentiated cancer therapies, announced that it has engaged IBN, a multifaceted financial news and publishing company, to support its corporate communications strategy. Through the engagement, IBN will leverage its investor-focused distribution platform, including more than 5,000 syndication outlets, newsletters, social media channels, blogs and wire services via InvestorWire, to increase awareness of LIXTE’s first-in-class approach to enhancing the effectiveness of existing chemotherapy and immunotherapy treatments, including its lead clinical candidate, LB-100, across cancers with significant unmet medical need. To view the full press release, visit https://ibn.fm/wlINV About LIXTE…

Continue Reading

ThursdayJan 08, 2026 9:00 am

TinyGemsBreaks – Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT) Expands Ovarian Cancer Trial With MD Anderson and GSK

Lixte Biotechnology Holdings (NASDAQ: LIXT) announced an expansion of its collaboration with The University of Texas MD Anderson Cancer Center and pharmaceutical manufacturer GSK on an ongoing clinical trial evaluating its proprietary compound LB-100 in combination with GSK’s Dostarlimab for the treatment of ovarian clear cell cancer. The trial, initiated in January 2024 and led by Amir Jazaeri, MD, at MD Anderson, has added a second site at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University under the direction of Emily M. Hinchcliff, MD, MPH, and is expected to double enrollment to 42 patients following completion of its…

Continue Reading

WednesdayDec 17, 2025 12:25 pm

TinyGemsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Appoints Rami Levin as President and Chief Executive Officer

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company developing treatments for primary and metastatic cancers of the brain and central nervous system, reported a leadership transition under which John Climaco has stepped down as chief executive officer and Rami Levin, MBA, has been appointed president and chief executive officer, effective Jan. 1, 2026. Levin brings nearly three decades of global leadership experience across oncology, neurology and rare diseases, with a track record of advancing late-stage clinical programs, scaling organizations and leading strategic turnarounds, positioning CNS to advance its pipeline and next phase of development. To view the full press release, visit https://ibn.fm/FBByV About CNS Pharmaceuticals, Inc. CNS Pharmaceuticals is a…

Continue Reading

MondayDec 15, 2025 9:10 am

TinyGemsBreaks – Datavault AI Inc. (NASDAQ: DVLT) Taps Hockey Hall of Famer Jeremy Roenick to Advise International NIL Exchange Initiative

Datavault AI (NASDAQ: DVLT), a provider of patented agentic AI platforms for data observation, valuation and monetization, today announced that Hockey Hall of Famer Jeremy Roenick is advising the Company on the development of its Sports and Entertainment initiative through the forthcoming International NIL Exchange, building on recent partnerships including the World Boxing Council and Dream Bowl. Roenick will support expansion of the platform, which is powered by Datavault AI patented Data Vault, DataScore(R) and DataValue(R) AI agents and enables indexing and tokenization of sports and entertainment assets for trading on the patented Information Data Exchange(R) via the New York…

Continue Reading

WednesdayDec 10, 2025 2:50 am

TinyGemsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) Announces Qubits 2026 Quantum Computing User Conference

D-Wave Quantum Inc. (NYSE: QBTS), (“D-Wave”) a leader in quantum computing systems, software and services, announced its annual Qubits user conference will take place January 27 and 28, 2026, in Boca Raton, Florida. Featuring talks from D-Wave’s executives, customers, industry leaders, and scientists, the event will highlight how the company’s energy-efficient annealing quantum computers and hybrid-quantum solvers are delivering measurable impact today. In addition, D-Wave will share its latest technology roadmap for both annealing and gate-model initiatives, underscoring its leadership in delivering commercial-grade superconducting quantum technology and outlining its strategic vision for the future. One of the premier quantum computing…

Continue Reading

MondayDec 01, 2025 11:10 am

TinyGemsBreaks – SEGG Media Corporation (NASDAQ: SEGG, LTRYW) Announces Leadership Changes as Board Appoints Robert Stubblefield Interim CEO

SEGG Media (NASDAQ: SEGG, LTRYW) said its Board terminated CEO, Secretary and President Matthew McGahan and removed him as Chairman, appointing CFO Robert Stubblefield as Interim CEO, Secretary and President and naming Marc Bircham Chairman. McGahan will remain a Director until his term expires at the upcoming annual meeting. The Company said the leadership transition supports its next phase of growth as it scales Sports.com, Concerts.com and Lottery.com, with more than 102 million views across platforms in 2025, and prepares for planned acquisitions. Stubblefield said the focus is on financial stability, disciplined execution and rebuilding shareholder value, while guiding expansion…

Continue Reading

MondayNov 17, 2025 11:01 am

TinyGemsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Reports Q3 Results and Advances Lead Candidate TPI 287 Toward Phase 2 GBM Study 

CNS Pharmaceuticals (NASDAQ: CNSP) reported third-quarter 2025 results and highlighted continued progress with TPI 287, its blood-brain barrier–permeable abeotaxane in development for glioblastoma and other CNS tumors. The Company noted Phase 1 data showing potential BBB penetration and tumor responses, including 3 complete and 9 partial responses among 23 evaluable patients treated with TPI 287 plus bevacizumab, and plans to engage the FDA early next year on a registration-focused Phase 2 trial design in recurrent GBM. For the quarter, CNS reported a net loss of $3.3 million, R&D expenses of $2.2 million and G&A expenses of $1.1 million, ending the…

Continue Reading

Contact us: (512) 354-7000